AtriCure (ATRC) Capital Expenditures (2010 - 2026)

AtriCure (ATRC) has reported Capital Expenditures for 17 consecutive years, with $3.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Capital Expenditures rose 41.47% year-over-year to $3.8 million in Q2 2026; TTM through Jun 2026 was $11.8 million, a 6.11% increase from a year earlier, with the FY2025 full-year figure at $9.0 million, down 21.02% from the prior year.
• Capital Expenditures was $3.8 million for Q2 2026 at AtriCure, down from $3.9 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $5.1 million in Q3 2022 and troughed at $1.6 million in Q4 2025.
• A 5-year average of $3.2 million and a median of $2.9 million in 2023 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures soared 242.09% in 2022 and slumped 40.51% in 2025, its largest moves.
• Over 5 years, Capital Expenditures stood at $4.2 million in 2022, then plunged by 33.21% to $2.8 million in 2023, then dropped by 3.34% to $2.7 million in 2024, then tumbled by 40.51% to $1.6 million in 2025, then jumped by 135.08% to $3.8 million in 2026.
• The last three Capital Expenditures figures came in at $3.8 million (Q2 2026), $3.9 million (Q1 2026), and $1.6 million (Q4 2025), per Business Quant data.